Table 4.
Comparison of general practitioner pharmacological management in period one and period two for knee and hip OA.
Knee OA Rate per 100 knee OA problems managed (95% CI) |
Hip OA Rate per 100 hip OA problems managed (95% CI) |
|||||||
---|---|---|---|---|---|---|---|---|
2005-10 |
2010-16 |
2005-10 |
2010-16 |
|||||
N | n=3,058 | N | n=4,156 | N | n=1,106 | N | n=1,492 | |
All medication | ||||||||
All | 2,365 | 77•3 (74•5-80•2) | 3,086 | 74•3 (71•7-76•8) | 836 | 75•6 (71•4-80•0) | 1,120 | 75•1 (70•8-79•4) |
New | 529 | 78•7 (73•2-84•2) | 722 | 75•2 (70•5-80•0) | 208 | 73•2 (64•7-81•8) | 258 | 69•5 (62•2-76•9) |
Prescribed | 1,818 | 59•5 (56•9-62•0) | 2,444 | 58•8 (56•5-61•1) | 717 | 64•8 (60•5-69•2) | 992 | 66•5 (62•3-70•6) |
Advised over counter | 344 | 11•3 (9•8-12•7) | 443 | 10•7 (9•5-11•9) | 96 | 8•7 (6•8-10•6) | 100 | 6•7 (5•3-8•1) |
Supplied | 203 | 6•6 (5•3-8•0) | 199 | 4•8 (3•9-5•7) | 23 | 2•1 (1•1-3•1) | 28 | 1•9 (1•0-2•7) |
NSAIDs | ||||||||
All | 862 | 28•2 (26•4-29•9) | 853 | 20•5 (19•2-21•9) * | 266 | 24•1 (21•4-26•7) | 261 | 17•5 (15•5-19•5) * |
New | 215 | 32•0 (28•4-35•6) | 218 | 22•7 (20•0-25•4) * | 70 | 24•6 (19•5-29•8) | 66 | 17•8 (13•7-21•8) |
Paracetamol | ||||||||
All | 693 | 22•7 (21•0-24•3) | 1,096 | 26•4 (24•9-27•9) * | 258 | 23•3 (20•7-25•9) | 357 | 23•9 (21•5-26•4) |
New | 156 | 25•7 (22•3-29•1) | 232 | 24•2 (21•4-26•9) | 79 | 27•8 (22•5-33•1) | 101 | 27•2 (22•5-32•0) |
Opioids | ||||||||
All | 316 | 10•3 (9•2-11•5) | 621 | 14•9 (13•7-16•2) * | 218 | 19•7 (17•0-22•5) | 382 | 25•6 (22•8-28•4) * |
New | 21 | 3•1 (1•8-4•5) | 65 | 6•8 (5•1-8•5) * | 27 | 9•5 (5•6-13•4) | 36 | 9•7 (6•5-13•0) |
Glucosamine | ||||||||
All | 148 | 4•8 (4•0-5•6) | 74 | 1•8 (1•4-2•2) * | 36 | 3•3 (2•2-4•3) | 10 | 0•7 (0•3-1•1) * |
New | 54 | 8•0 (6•0-10•1) | 26 | 2•7 (1•6-3•8) * | 19 | 6•7 (3•8-9•6) | 3 | 0•8 (0•0-1•7) * |
* significant difference compared with 2005-2010 time period.
NSAIDS=non steroidal anti-inflammatory drugs.